2-[(4-Ethylphenyl)-hydroxymethyl]prop-2-enenitrile | 1019450-89-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-[(4-Ethylphenyl)-hydroxymethyl]prop-2-enenitrile
• CAS: 1019450-89-5
• 化学式: C₁₂H₁₃NO
• 分子量: 187.241
• InChiKey: JRKCLIDSVVPWHR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  44
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-[(4-Ethylphenyl)-hydroxymethyl]prop-2-enenitrile 在 sodium nitrate 、 1-己基-3-甲基咪唑硫酸氢盐 、 ammonium acetate 作用下， 以 溶剂黄146 为溶剂， 生成 2-((Z)-5-((Z)-2-cyano-3-(4-ethylphenyl)allylidene)-4-oxo-2-thioxothiazolidin-3-yl)acetic acid
  参考文献：
  名称：

  Synthesis and biological evaluation of new epalrestat analogues as aldose reductase inhibitors (ARIs)

  摘要：

  Baylis-Hillman chemistry derived four series of new epalrestat analogues were synthesized. Three structural changes are introduced in these 39 new epalrestat analogues synthesized. All compounds were evaluated for their in vitro aldose reductase inhibitory (ALR) activity. Biological activity data indicates that compounds 6, 16, 19, 28 and 29 are potent and the activity is in the range of reference drug, epalrestat. Molecular modelling studies were performed to understand the binding interactions of these active molecules with the ALR protein. Molecular docking data indicates the key interactions of epalrestat were retained in some of the active compounds whereas some new interactions were noticed for other molecules. The modifications introduced on epalrestat have impact for developing a new-type of ALR inhibitor. (C) 2013 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2013.10.043
• 作为产物：
  描述：

  丙烯腈 、 4-乙基苯甲醛 在 三乙烯二胺 作用下， 生成 2-[(4-Ethylphenyl)-hydroxymethyl]prop-2-enenitrile
  参考文献：
  名称：

  从Baylis-Hillman反应的醛中高效无催化一锅合成伯酰胺

  摘要：

  在本文中，已经开发了一种在无催化剂条件下使用羟胺/甲醇系统从Baylis-Hillman加合物的醛制备烯丙基酰胺的简便有效的方法。研究了溶剂和温度对反应的影响以及苯环上的取代基。该方法的优点如操作简单，中等至极好的收率，较短的反应时间和简单的反应过程等得到了最好的证明。最重要的是，在没有催化剂和外部氧化剂的情况下，反应平稳进行。

  DOI：

  10.1039/c7nj01965c

文献信息

• Design, synthesis, and biological evaluation of 4-H pyran derivatives as antimicrobial and anticancer agents
  作者：Thatikonda Narendar Reddy、Mettu Ravinder、Raktani Bikshapathi、Pombala Sujitha、C. Ganesh Kumar、Vaidya Jayathirtha Rao

  DOI：10.1007/s00044-017-1982-y

  日期：2017.11

  A series of pyran derivatives (5–27) were synthesized in good yields by utilizing Baylis–Hillman chemistry and were further investigated for their in vitro anticancer, antibacterial, and antifungal activities. Most of the tested compounds exhibited promising antibacterial activity as compared to the standard towards Gram-positive bacterial strains. The compounds 5–7, 11–13, and 17–19 displayed two-fold

  利用Baylis–Hillman化学方法以高收率合成了一系列吡喃衍生物（5–27），并对其体外抗癌，抗菌和抗真菌活性进行了进一步研究。与针对革兰氏阳性细菌菌株的标准品相比，大多数测试化合物均显示出有希望的抗菌活性。化合物5-7，11-13和17-19显示的两个倍高的活性，而化合物21显示出针对4倍高的抗菌活性的金黄色葡萄球菌相比，新霉素标准96 MTCC。这些化合物中的一些对所有测试的真菌菌株均表现出中等的抗真菌活性。两种化合物图16和23显示了对选定的四种人类癌细胞系如A549，DU145，HeLa和MCF7的有希望的抗癌活性。
• Triphosgene mediated chlorination of Baylis–Hillman adducts
  作者：NARENDER REDDY THATIKONDA、NAGA SESHA SAI PAVAN KUMAR CHEBOLU、MAHENDAR BUDDE、JAYATHIRTHA RAO VAIDYA

  DOI：10.1007/s12039-012-0243-3

  日期：2012.3

  method for the preparation of allyl chlorides from Baylis–Hillman adducts has been developed using triphosgene/pyridine system. This method is best illustrated by its advantages like operational simplicity, excellent yields, short reaction time, simple procedure and stereoselectivity. The preparation of allyl chlorides from Baylis-Hillman adducts has been described using triphosgene & pyridine system

  使用三光气/吡啶体系开发了一种从Baylis-Hillman加合物制备烯丙基氯的有效方法。该方法的优点是操作简便，产率高，反应时间短，操作步骤简单和立体选择性好，这是最好的例证。 已经描述了使用三光气和吡啶体系从Baylis-Hillman加合物制备烯丙基氯。该方法的效率可以通过一些优点来最好地说明，例如操作简便，产率高，反应时间短，操作简单和立体选择性。
• Multicomponent Cascade Assembly for Quinolinopyranpyrazole Architectures
  作者：Manickam Bakthadoss、Anthonisamy Devaraj、Damodharan Kannan

  DOI：10.1002/ejoc.201301422

  日期：2014.3

  A highly efficient, multicomponent protocol for the construction of functionalized quinolinopyranpyrazole scaffolds with high stereoselectivity has been developed through the application of a domino reaction. All the quinolinopyranpyrazoles were synthesized under solvent- and catalyst-free conditions and required no work-up or column chromatography.

  通过多米诺反应的应用，开发了一种高效、多组分的方案，用于构建具有高立体选择性的功能化喹啉并吡唑支架。所有喹啉并吡唑均在无溶剂和无催化剂条件下合成，无需后处理或柱层析。
• An efficient catalyst-free one-pot synthesis of primary amides from the aldehydes of the Baylis–Hillman reaction
  作者：Thatikonda Narendar Reddy、Bikshapathi Raktani、Ramesh Perla、Mettu Ravinder、Jayathirtha Rao Vaidya、N. Jagadeesh Babu

  DOI：10.1039/c7nj01965c

  日期：——

  Herein, a facile and efficient method for the preparation of allyl amides from the aldehyde of Baylis–Hillman adducts has been developed using a hydroxylamine/methanol system under a catalyst-free condition. The effects of solvents and temperature on the reaction and substituents on the phenyl ring have been examined. This method is best demonstrated by its advantages such as operational simplicity

  在本文中，已经开发了一种在无催化剂条件下使用羟胺/甲醇系统从Baylis-Hillman加合物的醛制备烯丙基酰胺的简便有效的方法。研究了溶剂和温度对反应的影响以及苯环上的取代基。该方法的优点如操作简单，中等至极好的收率，较短的反应时间和简单的反应过程等得到了最好的证明。最重要的是，在没有催化剂和外部氧化剂的情况下，反应平稳进行。
• Synthesis and biological evaluation of new epalrestat analogues as aldose reductase inhibitors (ARIs)
  作者：Thatikonda Narendar Reddy、Mettu Ravinder、Pankaj Bagul、Keerthi Ravikanti、Chandrakant Bagul、Jagadeesh Babu Nanubolu、Kolupula Srinivas、Sanjay K. Banerjee、Vaidya Jayathirtha Rao

  DOI：10.1016/j.ejmech.2013.10.043

  日期：2014.1

  Baylis-Hillman chemistry derived four series of new epalrestat analogues were synthesized. Three structural changes are introduced in these 39 new epalrestat analogues synthesized. All compounds were evaluated for their in vitro aldose reductase inhibitory (ALR) activity. Biological activity data indicates that compounds 6, 16, 19, 28 and 29 are potent and the activity is in the range of reference drug, epalrestat. Molecular modelling studies were performed to understand the binding interactions of these active molecules with the ALR protein. Molecular docking data indicates the key interactions of epalrestat were retained in some of the active compounds whereas some new interactions were noticed for other molecules. The modifications introduced on epalrestat have impact for developing a new-type of ALR inhibitor. (C) 2013 Elsevier Masson SAS. All rights reserved.